INSIGHTS ON PHARMACEUTICAL INSPECTION

• EU And PIC/S Annex 1: CCS Shortfalls After 2 Years Of Implementation

  Explore how to elevate Contamination Control Strategies from static documents to inspection-ready, lifecycle tools, as well as practical approaches to Annex 1 compliance and risk-based CCS development.

• Ensuring Integrity: Testing Viscous Biologics In Pre-Filled Syringes

  Viscous biologics in pre-filled syringes demand precise integrity testing. Discover how advanced HVLD technology detects micro-defects and ensures sterility, meeting stringent USP <1207> standards.

• Part II: Defining The Dye Ingress Operating Window

  Learn about the viscosity-driven limits of dye ingress testing, translating qualitative constraints into a quantitative feasibility boundary shaped by defect size, pressure behavior, and plunger mechanics.

• Why A Dynamic, Digital Defect Library Is Now A Regulatory Expectation

  Maintaining a dynamic, digital defect library is essential for modern sterile manufacturing. Learn how this approach helps ensure consistency in batch disposition and supports regulatory compliance.

• Unlock Smart Production: The Key Role Of Checkweighing

  12/16/2024

  In today's fast-paced production, precision checkweighing is crucial. Discover how smart algorithms, real-time analysis, and automation optimize performance and minimize downtime.

• Ophthalmic Product Package Inspection

  1/5/2026

  Microscopic leaks in ophthalmic packaging can compromise sterility and patient safety. Learn how advanced vacuum decay testing delivers fast, reliable results, detecting defects as small as 5 microns.

• ICP-MS And ICP-OES: Tools For Elemental Impurity Analysis

  12/11/2024

  Leverage advanced elemental impurity testing methods to ensure the safety, compliance, and accuracy of your drug products throughout the manufacturing process.

• A Holistic Approach To CCI Is A Deterministic Approach

  1/30/2026

  A modern approach to CCI blends smart design, risk‑based strategies, and deterministic testing to safeguard sterile products. Learn how lifecycle thinking and practical sampling plans strengthen quality.

• Visual Inspection Of Advanced Therapy Medicinal Products

  9/2/2025

  Discover how expert database systems for inspection defect management and control help cell and gene therapies meet the requirements of USP-790 to assure they are essentially free from particulate matter.